This inventor holds 1 USPTO granted patent. Top assignee: Yangzhou University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Qiuqi Kan: Innovator in Peptide Antigen Research
Introduction
Qiuqi Kan is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of peptide antigens related to the novel coronavirus SARS-CoV-2. His work is crucial in the ongoing fight against COVID-19.
Latest Patents
Qiuqi Kan holds a patent titled "Broad-Spectrum Peptide Antigen of the Novel Coronavirus SARS-CoV-2, Specific Neutralizing Antibody and Use Thereof." This patent represents a significant advancement in the development of vaccines and therapeutic agents against the virus. He has 1 patent to his name.
Career Highlights
Kan is affiliated with Yangzhou University, where he conducts research and collaborates with other scientists. His work focuses on innovative solutions to combat viral infections, showcasing his commitment to public health and safety.
Collaborations
He has worked alongside notable colleagues such as Jianqiang Ye and Tuofan Li. Their combined expertise enhances the research output and effectiveness of their projects.
Conclusion
Qiuqi Kan's contributions to peptide antigen research are vital in addressing global health challenges. His innovative work continues to pave the way for advancements in vaccine development and therapeutic strategies.